Charles J. Schleupner

735 total citations
30 papers, 562 citations indexed

About

Charles J. Schleupner is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Charles J. Schleupner has authored 30 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 10 papers in Infectious Diseases and 10 papers in Pharmacology. Recurrent topics in Charles J. Schleupner's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Pneumonia and Respiratory Infections (7 papers) and Antibiotic Resistance in Bacteria (7 papers). Charles J. Schleupner is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Pneumonia and Respiratory Infections (7 papers) and Antibiotic Resistance in Bacteria (7 papers). Charles J. Schleupner collaborates with scholars based in United States. Charles J. Schleupner's co-authors include S J Sperber, L. A. Glasgow, John R. Hamilton, John A. Armstrong, M. Ho, David S. Krause, Vinod K. Rustgi, James C. Overall, Thomas M. Kerkering and Jean A. Smith and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Charles J. Schleupner

30 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles J. Schleupner United States 15 287 197 70 68 65 30 562
Venusto H. San Joaquin United States 11 139 0.5× 228 1.2× 78 1.1× 70 1.0× 61 0.9× 26 647
S.J. Pedler United Kingdom 16 221 0.8× 229 1.2× 73 1.0× 36 0.5× 61 0.9× 32 588
Allan J. Morrison United States 13 155 0.5× 195 1.0× 169 2.4× 103 1.5× 39 0.6× 19 739
A Digranes Norway 17 310 1.1× 193 1.0× 130 1.9× 39 0.6× 111 1.7× 46 747
W Marget Germany 16 387 1.3× 238 1.2× 85 1.2× 78 1.1× 139 2.1× 106 935
A.M. Kambal Saudi Arabia 15 261 0.9× 151 0.8× 107 1.5× 25 0.4× 23 0.4× 47 649
Sverker Bernander Sweden 17 371 1.3× 223 1.1× 84 1.2× 63 0.9× 20 0.3× 31 1.2k
Asbjørn Digranes Norway 15 435 1.5× 315 1.6× 96 1.4× 27 0.4× 76 1.2× 55 794
Antonia Kolokathis United States 12 442 1.5× 363 1.8× 48 0.7× 23 0.3× 75 1.2× 15 788
Hisashi Baba Japan 15 185 0.6× 293 1.5× 56 0.8× 22 0.3× 91 1.4× 43 616

Countries citing papers authored by Charles J. Schleupner

Since Specialization
Citations

This map shows the geographic impact of Charles J. Schleupner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles J. Schleupner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles J. Schleupner more than expected).

Fields of papers citing papers by Charles J. Schleupner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles J. Schleupner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles J. Schleupner. The network helps show where Charles J. Schleupner may publish in the future.

Co-authorship network of co-authors of Charles J. Schleupner

This figure shows the co-authorship network connecting the top 25 collaborators of Charles J. Schleupner. A scholar is included among the top collaborators of Charles J. Schleupner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles J. Schleupner. Charles J. Schleupner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Johnson, A. Earl, et al.. (2022). Examining drivers of coronavirus disease 2019 (COVID-19) vaccine hesitancy among healthcare workers. Infection Control and Hospital Epidemiology. 43(12). 1813–1821. 12 indexed citations
3.
Fazili, Tasaduq, et al.. (2021). <i>Ehrlichia chaffeensis</i><i>-</i>associated Hemophagocytic Lymphohistiocytosis: A Case Series and Literature Review. American Journal of Medical Case Reports. 9(11). 557–563. 1 indexed citations
4.
Kerkering, Thomas M., et al.. (2013). Early Clinical Observations in Prospectively Followed Patients With Fungal Meningitis Related to Contaminated Epidural Steroid Injections. Annals of Internal Medicine. 158(3). 154–161. 37 indexed citations
5.
Schleupner, Charles J.. (1997). Urinary tract infections. Postgraduate Medicine. 101(6). 231–237. 18 indexed citations
6.
Bernstein, David I., Charles J. Schleupner, Thomas G. Evans, et al.. (1997). Effect of foscarnet cream on experimental UV radiation-induced herpes labialis. Antimicrobial Agents and Chemotherapy. 41(9). 1961–1964. 17 indexed citations
7.
Rustgi, Vinod K., Charles J. Schleupner, & David S. Krause. (1995). Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults. Vaccine. 13(17). 1665–1668. 18 indexed citations
8.
9.
Schleupner, Charles J., et al.. (1992). A Study of the Etiologies and Treatment of Nosocomial Pneumonia in a Community-Based Teaching Hospital. Infection Control and Hospital Epidemiology. 13(9). 515–525. 36 indexed citations
10.
Schleupner, Charles J.. (1988). Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections. Archives of Internal Medicine. 148(2). 343–348. 2 indexed citations
11.
Schleupner, Charles J., et al.. (1987). Effect of Ketoconazole on the 11-Hydroxylation Step of Adrenal Steroidogenesis. Southern Medical Journal. 80(6). 725–728. 4 indexed citations
12.
Sperber, S J & Charles J. Schleupner. (1987). Salmonellosis During Infection with Human Immunodeficiency Virus. Clinical Infectious Diseases. 9(5). 925–934. 123 indexed citations
13.
Schleupner, Charles J., et al.. (1986). Comparative multicentre evaluation of the safety and efficacy of ceftazidime versos cefamandole for pneumonia. Journal of Antimicrobial Chemotherapy. 18(4). 521–529. 3 indexed citations
14.
Schleupner, Charles J.. (1985). Clinical experience with cefotaxime for the therapy of bacteremias due to gram-positive organisms. Infection. 13(S1). S28–S33. 3 indexed citations
15.
Schleupner, Charles J., et al.. (1985). Comparison of ceftazidime with cefamandole for therapy of community-acquired pneumonia. Antimicrobial Agents and Chemotherapy. 28(1). 146–148. 9 indexed citations
16.
Schleupner, Charles J., et al.. (1982). Mycobacterium fortuitum as a Cause of Mastoiditis and Wound Infection. Archives of Otolaryngology - Head and Neck Surgery. 108(1). 11–14. 24 indexed citations
17.
Schleupner, Charles J., et al.. (1982). Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections. Antimicrobial Agents and Chemotherapy. 21(2). 327–333. 15 indexed citations
18.
Schleupner, Charles J. & John R. Hamilton. (1980). A Pseudoepidemic of Pulmonary Fungal Infections Related to Fiberoptic Bronchoscopy. Infection Control. 1(1). 38–43. 32 indexed citations
19.
Schleupner, Charles J. & L. A. Glasgow. (1978). Peritoneal macrophage activation indicated by enhanced chemiluminescence. Infection and Immunity. 21(3). 886–895. 37 indexed citations
20.
Schleupner, Charles J., Bosko Postic, John A. Armstrong, Robert W. Atchison, & M. Ho. (1969). Two Variants of Sindbis Virus Which Differ in Interferon Induction and Serum Clearance. II. Virological Characterizations. The Journal of Infectious Diseases. 120(3). 348–355. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Venusto H. San Joaquin Breakdown of academic impact, for papers by S.J. Pedler Breakdown of academic impact, for papers by Allan J. Morrison Breakdown of academic impact, for papers by A Digranes Breakdown of academic impact, for papers by W Marget Breakdown of academic impact, for papers by A.M. Kambal Breakdown of academic impact, for papers by Sverker Bernander Breakdown of academic impact, for papers by Asbjørn Digranes Breakdown of academic impact, for papers by Antonia Kolokathis Breakdown of academic impact, for papers by Hisashi Baba
Rankless by CCL
2026